TIBURIO THERAPEUTICS
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.The company's compounds aid in the treatment of non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule that has the potential to shrink or halt tumor growth, providing patients with effective treatment for rare neuroendocrine tumors and endocrine diseases.
TIBURIO THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tiburio.com
Total Employee:
1+
Status:
Active
Contact:
+1 (617) 231-6050
Email Addresses:
[email protected]
Total Funding:
31 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon Organization Schema
Similar Organizations
Aclipse Therapeutics
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Adagio Medical
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
Alivio Therapeutics
Alivio Therapeutics is pioneering a new way to treat inflammatory diseases based on precisely tuning the immune system.
AmbAgon Therapeutics
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
Boston Therapeutics
Boston Therapeutics develops and commercializes novel compounds for unmet medical needs in the areas of diabetes and inflammatory diseases.
Cellix Bio
Cellix Bio provides medical research services to develop drug products for the treatment of immune and other related diseases.
Starton Therapeutics
Starton Therapeutics is a biotechnology company focused on transforming standard of care therapeutics.
Cognos Therapeutics
Cognos Therapeutics is a developer of diagnostic and drug delivery devices to detect diseases and deliver drugs.
DeVoro Medical
DeVoro Medical is a developer of a medical device intended to restore blood flow.
dNovo Bio
Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Earli
Earli is a developer of cancer treatment devices designed to search for natural biomarkers.
EIP Pharma
EIP Pharma Provides Healthcare Services.
Engrail Therapeutics
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Fimecs
FIMECS is a focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases.
Forendo Pharma
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
Karuna Therapeutics
Karuna Therapeutics is a Massachusetts-based developer of drugs for the treatment of schizophrenia.
LSK BioPharma
LSK BioPharma specializes in clinical development of promising therapies for unmet medical needs in cancer.
MiNDERA Corporation
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
Neuron23
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Nivien Therapeutics
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PuREC
PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.
Qool Therapeutics
Qool Therapeutics is dedicated to creating non-invasive, efficient temperature management therapies to preserve cells.
Redpin Therapeutics
Redpin Therapeutics is a preclinical stage gene therapy company that develops chemogenetics platform designed for nervous system diseases.
ReShape Lifesciences
ReShape Lifesciencesis a developer of minimally invasive medical devices to treat obesity and metabolic diseases.
Retrotope
Retrotope is a developer of a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases.
Sana Biotechnology
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Serenity Pharmaceuticals
Serenity Pharmaceuticals is a developer of products that address urinary conditions.
SOM Biotech
Drug innovation company based on a pioneering AI-based drug discovery technology, that has built a robust pipeline for Orphan CNS diseases.
Spatial Genomics
Spatial Genomics is a developer of sequential fluorescence in situ hybridization (seqFISH) technology.
Vedanta Biosciences
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases.
Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
ViewPoint Therapeutics
ViewPoint Therapeutics is a developer of crystallin stabilizers intended to prevent and treat cataracts and presbyopia.
Current Employees Featured
Founder
Investors List
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series A - Tiburio Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series A - Tiburio Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Tiburio Therapeutics
Longitude Capital
Longitude Capital investment in Series A - Tiburio Therapeutics
Official Site Inspections
http://www.tiburio.com
- Host name: ec2-3-64-163-50.eu-central-1.compute.amazonaws.com
- IP address: 3.64.163.50
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
